WMS Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,685
Closed -$233K 246
2020
Q3
$233K Hold
2,685
0.05% 200
2020
Q2
$235K Hold
2,685
0.05% 189
2020
Q1
$221K Sell
2,685
-280
-9% -$25K 0.06% 170
2019
Q4
$281K Hold
2,965
0.06% 184
2019
Q3
$258K Hold
2,965
0.06% 190
2019
Q2
$271K Buy
+2,965
New +$251K 0.07% 171
2015
Q3
Sell
-6,006
Closed -$529K 242
2015
Q2
$529K Buy
6,006
+76
+1% +$6.97K 0.06% 165
2015
Q1
$524K Buy
+5,930
New +$526K 0.06% 158

Other funds holding NVS

WMS Partners's NVS Position: Q4 2020 in Review

WMS Partners sold out of Novartis (NVS) in Q4 2020, closing a stake of 2,685 shares — an estimated $233K sold.

WMS Partners first reported a position in NVS in Q1 2015 and held it in 8 quarters. The position peaked at $529K in Q2 2015. 1,176 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

  • WMS Partners reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
  • WMS Partners sold 2,685 Novartis shares in Q4 2020, an estimated $233K.
  • WMS Partners first reported a position in Novartis in Q1 2015 and held it in 8 quarters.
  • WMS Partners's Novartis position peaked at $529K in Q2 2015.
  • 1,176 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on WMS Partners's 13F filing for Q4 2020, filed 12 Feb 2021.